The WHO target is to eliminate cervical cancer by 2030, and recommends a combination of primary, secondary and tertiary prevention, including HPV immunization in girls under 15 years, screening of women of reproductive age (WRA) and early treatment of cervical cancer. Indonesia started a national programme of screening of WRA in 2007, but coverage was low. A pilot of HPV vaccination was started in Jakarta in 2016 and has since been slowly rolled out to a number of other locations.
The Cancer Research UK assigned Savica to conduct preliminary scoping work into the knowledge gaps in the opportunities, obstacles and solutions for improving HPV vaccine access or uptake in Indonesia. Document review and qualitative data collection were undertaken in early 2022, in close collaboration with one of Indonesia’s experts in the field.
